MoneyWorks4Me

Kilitch Drugs(India) - Quaterly Results

29 May 2023 Evaluate
A decent increase of about 35.13% in the sales to Rs. 432.83 millions was observed for the quarter ended March 2023. The sales figure stood at Rs. 320.31 millions during the year-ago period.The Profit  for the quarter ended March 2023 of  Rs. 51.28  millions  grew by 69.63% from Rs. 30.23 millions.Operating Profit saw a handsome growth to 81.19 millions from 47.45 millions in the quarter ended March 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 432.83 320.31 35.13 1177.84 1051.60 12.00 1177.84 1051.60 12.00
Other Income 14.32 7.68 86.46 45.98 45.59 0.86 45.98 45.59 0.86
PBIDT 81.19 47.45 71.11 217.71 155.54 39.97 217.71 155.54 39.97
Interest 4.07 1.77 129.94 9.85 6.63 48.57 9.85 6.63 48.57
PBDT 77.12 45.68 68.83 207.86 148.91 39.59 207.86 148.91 39.59
Depreciation 3.73 2.59 44.02 13.37 9.64 38.69 13.37 9.64 38.69
PBT 73.39 43.09 70.32 194.49 139.27 39.65 194.49 139.27 39.65
TAX 22.11 12.86 71.93 37.31 34.01 9.70 37.31 34.01 9.70
Deferred Tax 1.70 -1.45 -217.24 -4.66 -2.33 100.00 -4.66 -2.33 100.00
PAT 51.28 30.23 69.63 157.18 105.26 49.33 157.18 105.26 49.33
Equity 155.82 155.82 0.00 155.82 155.82 0.00 155.82 155.82 0.00
PBIDTM(%) 18.76 14.81 26.62 18.48 14.79 24.97 18.48 14.79 24.97
Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..